Merieux Equity Partners is a European healthcare-specialized investment firm established in 2009, managing over 1.5 billion euros in assets. The company invests in transformative health products and services through venture capital and buyout platforms, targeting startups to established leaders. With a focus on Europe and opportunistic investments in the United States, Merieux Equity Partners leverages its extensive healthcare network and expertise to support growth and innovation.
- Pharmaceuticals
- Specialty Chemicals
- Healthcare
- Life Sciences
- Chemical Manufacturing
- Biotechnology
- Active Pharmaceutical Ingredients (Ap Is)
- Pharmaceutical Intermediates
- Personal Care Ingredients
- Sustainable Development
Leadership
| Name | Title | ||
|---|---|---|---|
| Thierry Chignon | Managing Partner |
in/thierry-chignon-0616232
|
|
| Managing Partner |
|
|
|
| Managing Partner |
|
||
| Partner |
|
|
|
| Partner |
|
|
|
| Director |
|
||
| Managing partner |
|
|
|
| Director |
|
|
|
| Managing partner |
|
|
|
| Director |
|
|
Recent Transactions involving Mérieux Equity Partners
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Mérieux Equity Partners acquires a majority stake in Piercan, the worldleading technical gloves manufacturer for the pharmaceutical and nuclear industries. Groupe Siparex invests alongside Mérieux Equity Partners through its ETI and France Nucléaire funds. |
Piercan |
SiparexMérieux Equity Partners |
Pharmaceutical Manufacturing | |
|
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →